Hino, Japan

Masahiro Koga

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Koga. Retrieved from https://idiyas.com/inventor/masahiro-koga-ndrmz4ve

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Koga: Innovator in Pharmaceutical Chemistry

Introduction

Masahiro Koga is a prominent inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential. His work has led to the creation of innovative substances that may have important applications in medicine.

Latest Patents

Koga holds a patent for "Substituted pyrrolo[3,2-d]pyrimidine derivatives," which are compounds exhibiting GSK-3 inhibitory activity. This patent highlights his expertise in synthesizing complex chemical structures that can influence biological pathways. The patent details various chemical groups and their configurations, showcasing Koga's deep understanding of organic chemistry.

Career Highlights

Masahiro Koga is associated with Teijin Pharma Limited, a company known for its commitment to advancing healthcare through innovative pharmaceutical solutions. His role at the company has allowed him to focus on research and development, contributing to the advancement of new therapeutic agents.

Collaborations

Koga has collaborated with notable colleagues, including Takaharu Tsutsumi and Satoshi Sugiura. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the pharmaceutical field.

Conclusion

Masahiro Koga's contributions to pharmaceutical chemistry and his innovative patents underscore his role as a key figure in the industry. His work continues to pave the way for new therapeutic options that may benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…